Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
Stimulant medications used as first-line treatment in attention deficit hyperactivity disorder (ADHD) are contraindicated in patients with glaucoma. We present the first reported case of using methylphenidate therapy to safely and effectively treat ADHD in a pediatric patient with glaucoma.
Department of Pediatrics, Joan C. Edwards School of Medicine at Marshall University, 1600 Medical Center Drive, Huntington, WV 25701, USA. Hlewis1@health.usf.edu
Heidi
H
Lewis
James
J
Lewis
D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D000075202:Contraindications; D003692:Delayed-Action Preparations / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008774:Methylphenidate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000697:Central Nervous System Stimulants; D003692:Delayed-Action Preparations; D008774:Methylphenidate